Literature DB >> 15165985

Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes.

Birgit Bölck1, Götz Münch, Peter Mackenstein, Martin Hellmich, Ingo Hirsch, Hannes Reuter, Nadja Hattebuhr, Hans-Jörg Weig, Martin Ungerer, Klara Brixius, Robert H G Schwinger.   

Abstract

The Na(+)/Ca(2+) exchanger (NCX) may influence cardiac function depending on its predominant mode of action, forward mode or reverse mode, during the contraction-relaxation cycle. The intracellular Na(+) concentration ([Na(+)](i)) and the duration of the action potential as well as the level of NCX protein expression regulate the mode of action of NCX. [Na(+)](i) and NCX expression have been reported to be increased in human heart failure. Nevertheless, the consequences of altered NCX expression in heart failure are still a matter of discussion. We aimed to characterize the influence of NCX expression on intracellular Ca(2+) transport in rat cardiomyocytes by adenoviral-mediated gene transfer. A five- to ninefold (dose dependent) overexpression of NCX protein was achieved after 48 h by somatic gene transfer (Ad.NCX.GFP) versus control (Ad.GFP). NCX activity, determined by Na(+) gradient-dependent (45)Ca(2+)-uptake, was significantly increased. The protein expressions of sarco(endo)plasmic reticulum Ca(2+)-ATPase, phospholamban, and calsequestrin were unaffected by NCX overexpression. Fractional shortening (FS) of isolated cardiomyocytes was significantly increased at low stimulation rates in Ad.NCX.GFP. After a step-wise enhancing frequency of stimulation to 3.0 Hz, FS remained unaffected in Ad.GFP cells but declined in Ad.NCX.GFP cells. The positive inotropic effect of the cardiac glycoside ouabain was less effective in Ad.NCX.GFP cells, whereas the positive inotropic effect of beta-adrenergic stimulation remained unchanged. In conclusion, NCX overexpression results in a reduced cell shortening at higher stimulation frequencies as well as after inhibition of sarcolemmal Na(+)-K(+)-ATPase, i.e., in conditions with enhanced [Na(+)](i). At low stimulation rates, increased NCX expression enhances both intracellular systolic Ca(2+) and contraction amplitude.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165985     DOI: 10.1152/ajpheart.00397.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

Review 1.  [Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure].

Authors:  Klara Brixius; Konrad F Frank; Birgit Bölck; Felix Hoyer; Robert H G Schwinger
Journal:  Wien Med Wochenschr       Date:  2006-04

Review 2.  Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(2+) leak as a novel therapeutic approach.

Authors:  Stefan Neef; Lars S Maier
Journal:  Curr Heart Fail Rep       Date:  2007-03

3.  Na(+)/Ca(2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart.

Authors:  A S Farkas; K Acsai; N Nagy; A Tóth; F Fülöp; G Seprényi; P Birinyi; P P Nánási; T Forster; M Csanády; J G Papp; A Varró; A Farkas
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

Review 4.  SERCA2a in heart failure: role and therapeutic prospects.

Authors:  Davide Gianni; Joachim Chan; Judith K Gwathmey; Federica del Monte; Roger J Hajjar
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

5.  Chromatin remodelling complex dosage modulates transcription factor function in heart development.

Authors:  Jun K Takeuchi; Xin Lou; Jeffrey M Alexander; Hiroe Sugizaki; Paul Delgado-Olguín; Alisha K Holloway; Alessandro D Mori; John N Wylie; Chantilly Munson; Yonghong Zhu; Yu-Qing Zhou; Ru-Fang Yeh; R Mark Henkelman; Richard P Harvey; Daniel Metzger; Pierre Chambon; Didier Y R Stainier; Katherine S Pollard; Ian C Scott; Benoit G Bruneau
Journal:  Nat Commun       Date:  2011-02-08       Impact factor: 14.919

6.  The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.

Authors:  Karen M O'Shea; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Devi Thiagarajan; Gopalkrishna Sreejit; Lingjie Wang; Hylde Zirpoli; Juan Francisco Aranda; Arthur S Alberts; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  EBioMedicine       Date:  2017-11-21       Impact factor: 8.143

Review 7.  Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Adverse Drug-Induced Inotropic Effects in Early Drug Development. Part 1: General Considerations for Development of Novel Testing Platforms.

Authors:  Brian D Guth; Michael Engwall; Sandy Eldridge; C Michael Foley; Liang Guo; Gary Gintant; John Koerner; Stanley T Parish; Jennifer B Pierson; Alexandre J S Ribeiro; Tanja Zabka; Khuram W Chaudhary; Yasunari Kanda; Brian Berridge
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

Review 8.  Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy.

Authors:  Vera Paar; Peter Jirak; Robert Larbig; Naufal Shamilevich Zagidullin; Mathias C Brandt; Michael Lichtenauer; Uta C Hoppe; Lukas J Motloch
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.